Research Article
Risk Factors for Sepsis Based on Sepsis-3 Criteria after Orthotopic Liver Transplantation
Table 2
Prognosis of patients with or without orthotopic liver transplantation- (OLT-) related sepsis (reported as
(%), unless otherwise noted).
| | Sepsis-negative | Sepsis-positive | |
| | Subjects, | 41 | 85 | — | | Dialysis | 2 (4.8) | 42 (49.4) | <0.001 | | Reintubation/tracheostomy | 3 (7.3) | 16 (18.8) | 0.334 | | Fiber bronchoscope suction | 8 (19.5) | 10 (11.7) | 0.543 | | Medicines after OLT | | | | | Alprostadil | 19 (46.3) | 21 (24.7) | 0.052 | | Terlipressin | 6 (14.6) | 10 (11.8) | 0.880 | | RhIL-11a | 17 (41.5) | 19 (22.4) | 0.071 | | Duration of ICUb stay, d | 3 (2–5) | 3.5 (2–10) | 0.072 | | Mechanical ventilation, d | 1 (1–1) | 1.5 (1–3) | 0.022 | | Returning to ICU | 3 (7.3) | 14 (16.5) | 0.438 | | Hospitalization after OLT, d | 35 (28–48) | 44 (38–63) | 0.066 | | Hospitalization costs, 106 RMBc | 0.30 (0.24–0.34) | 0.41 (0.34–0.63) | <0.001 |
|
|
aRhIL-11: recombinant human interleukin 11; bICU: intensive care unit; cRMB: Chinese renminbi.
|
